5-80654962-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002439.5(MSH3):āc.235A>Gā(p.Ile79Val) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.771 in 1,473,312 control chromosomes in the GnomAD database, including 441,703 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/24 in silico tools predict a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_002439.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSH3 | ENST00000265081.7 | c.235A>G | p.Ile79Val | missense_variant, splice_region_variant | 1/24 | 1 | NM_002439.5 | ENSP00000265081.6 | ||
MSH3 | ENST00000667069.1 | c.235A>G | p.Ile79Val | missense_variant, splice_region_variant | 1/22 | ENSP00000499502.1 | ||||
DHFR | ENST00000439211.7 | c.-473T>C | 5_prime_UTR_variant | 1/6 | 1 | NM_000791.4 | ENSP00000396308.2 | |||
MSH3 | ENST00000670357.1 | n.235A>G | splice_region_variant, non_coding_transcript_exon_variant | 1/25 | ENSP00000499791.1 |
Frequencies
GnomAD3 genomes AF: 0.794 AC: 120111AN: 151286Hom.: 48045 Cov.: 29
GnomAD3 exomes AF: 0.857 AC: 68817AN: 80302Hom.: 30076 AF XY: 0.854 AC XY: 38527AN XY: 45132
GnomAD4 exome AF: 0.769 AC: 1016019AN: 1321920Hom.: 393618 Cov.: 28 AF XY: 0.768 AC XY: 500553AN XY: 651620
GnomAD4 genome AF: 0.794 AC: 120200AN: 151392Hom.: 48085 Cov.: 29 AF XY: 0.789 AC XY: 58349AN XY: 73916
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 22, 2018 | This variant is associated with the following publications: (PMID: 10944853) - |
Hereditary cancer-predisposing syndrome Benign:2
Benign, criteria provided, single submitter | curation | Sema4, Sema4 | Feb 19, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 10, 2018 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Constitutional megaloblastic anemia with severe neurologic disease Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 29, 2023 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at